DIA 2015 Editor’s Take – MedPoint Digital

Post By dgauthier@medpt.com

In this interview, Bill Cooney discusses the need for the clinical research community to consider the digital patient in the larger context of consumer and healthcare markets, where advances are more rapid and profound. In coming years, clinical research will be challenged merely to keep pace with how mobile devices, apps and cloud technology transform consumer behavior.

To avoid falling far behind the expectations of digital patients, drug developers need to immediately start using apps and mobile devices in trials. Cooney points out the, while some sponsors are conducting pilots seeking to transform the paradigm for clinical trials, other sponsors can use new digital formats in safer, more modest ways, and should start doing so immediately.